Published in Diabetes Care on October 01, 2004
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS One (2008) 1.68
Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas. J Diabetes Investig (2013) 1.55
Anti-vascular endothelial growth factor therapy for diabetic macular edema. Ther Adv Endocrinol Metab (2013) 1.34
A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol (2012) 1.33
A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond) (2014) 1.30
Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci Transl Med (2015) 1.27
Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care (2011) 1.23
Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes. J Clin Endocrinol Metab (2012) 1.20
The pericyte: cellular regulator of microvascular blood flow. Microvasc Res (2009) 1.19
Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy. BMC Med Genet (2010) 1.15
The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy. Health Qual Life Outcomes (2008) 1.13
Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina. Am J Pathol (2006) 1.10
Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J Endocrinol Metab (2016) 1.09
Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC Pediatr (2009) 1.08
Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog Retin Eye Res (2010) 1.06
Validating retinal fundus image analysis algorithms: issues and a proposal. Invest Ophthalmol Vis Sci (2013) 1.03
Pericyte Rho GTPase mediates both pericyte contractile phenotype and capillary endothelial growth state. Am J Pathol (2007) 1.00
Effects of modified LDL and HDL on retinal pigment epithelial cells: a role in diabetic retinopathy? Diabetologia (2013) 0.98
Morphology and topography of retinal pericytes in the living mouse retina using in vivo adaptive optics imaging and ex vivo characterization. Invest Ophthalmol Vis Sci (2013) 0.98
Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy. Indian J Ophthalmol (2010) 0.97
Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies. Eye (Lond) (2011) 0.96
NADPH Oxidase versus Mitochondria-Derived ROS in Glucose-Induced Apoptosis of Pericytes in Early Diabetic Retinopathy. J Ophthalmol (2010) 0.95
The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol (2006) 0.94
miR-15b/16 protects primary human retinal microvascular endothelial cells against hyperglycemia-induced increases in tumor necrosis factor alpha and suppressor of cytokine signaling 3. J Neuroinflammation (2015) 0.92
Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology. Br J Pharmacol (2012) 0.92
Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2014) 0.90
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Vasc Health Risk Manag (2009) 0.90
Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy. Clin Ophthalmol (2012) 0.89
A lipidomic screen of hyperglycemia-treated HRECs links 12/15-Lipoxygenase to microvascular dysfunction during diabetic retinopathy via NADPH oxidase. J Lipid Res (2015) 0.89
Hypertension and type 2 diabetes: a cross-sectional study in Morocco (EPIDIAM Study). Pan Afr Med J (2012) 0.88
[Diabetic retinopathy: comparison of the diagnostic features of ultra-widefield scanning laser ophthalmoscopy Optomap with ETDRS 7-field fundus photography]. Ophthalmologe (2011) 0.87
Validation of Smartphone Based Retinal Photography for Diabetic Retinopathy Screening. PLoS One (2015) 0.86
Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy. Int Ophthalmol (2010) 0.84
Steroid-induced diabetes: is it just unmasking of type 2 diabetes? ISRN Endocrinol (2012) 0.84
Endothelial progenitor cells in diabetic retinopathy. Front Endocrinol (Lausanne) (2014) 0.83
PKCζ mediates breakdown of outer blood-retinal barriers in diabetic retinopathy. PLoS One (2013) 0.82
Yang Deficiency Body Constitution Acts as a Predictor of Diabetic Retinopathy in Patients with Type 2 Diabetes: Taichung Diabetic Body Constitution Study. Evid Based Complement Alternat Med (2015) 0.81
Intravitreal Corticosteroids in the Management of Diabetic Macular Edema. Curr Ophthalmol Rep (2013) 0.81
Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases. PLoS One (2014) 0.81
Ocular Complications of Diabetes and Therapeutic Approaches. Biomed Res Int (2016) 0.80
Diabetic Retinopathy-Update on Prevention Techniques, Present Therapies, and New Leads. US Ophthalmic Rev (2014) 0.80
Changes of total antioxidant capacity and total oxidant status of aqueous humor in diabetes patients and correlations with diabetic retinopathy. Int J Ophthalmol (2013) 0.80
Retinal Neurodegeneration in db/db Mice at the Early Period of Diabetes. J Ophthalmol (2015) 0.80
Origins and consequences of hyperosmolar stress in retinal pigmented epithelial cells. Front Physiol (2014) 0.80
Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases. Mediators Inflamm (2014) 0.80
Predictive factors of diabetic complications: a possible link between family history of diabetes and diabetic retinopathy. J Diabetes Metab Disord (2014) 0.80
The association between retinal vascular geometry changes and diabetic retinopathy and their role in prediction of progression--an exploratory study. BMC Ophthalmol (2014) 0.80
Neuroretinal alterations in the early stages of diabetic retinopathy in patients with type 2 diabetes mellitus. Eye (Lond) (2016) 0.80
Treatment of diabetic retinopathy: Recent advances and unresolved challenges. World J Diabetes (2016) 0.79
Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes. Yonsei Med J (2013) 0.79
Plasma and vitreous fluid levels of Dickkopf-1 in patients with diabetic retinopathy. Eye (Lond) (2014) 0.79
High-Fat Diet-Induced Retinal Dysfunction. Invest Ophthalmol Vis Sci (2015) 0.79
Statistics of optical coherence tomography data from human retina. IEEE Trans Med Imaging (2010) 0.79
Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab. Int J Ophthalmol (2015) 0.79
Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients. Mol Vis (2015) 0.79
Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study. Clin Ophthalmol (2013) 0.78
Dysfunction of circulating endothelial progenitor cells in type 1 diabetic rats with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2013) 0.78
Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy. Int J Ophthalmol (2015) 0.78
Trial by CCN2: a standardized test for fibroproliferative disease? J Cell Commun Signal (2009) 0.78
Transgenic Mice Overexpressing Serum Retinol-Binding Protein Develop Progressive Retinal Degeneration through a Retinoid-Independent Mechanism. Mol Cell Biol (2015) 0.78
Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials. Clin Ophthalmol (2016) 0.78
High cystatin C levels predict severe retinopathy in type 2 diabetes patients. Eur J Epidemiol (2013) 0.78
Antisense oligonucleotide therapy in diabetic retinopathy. J Diabetes Sci Technol (2009) 0.78
Predictors of insulin resistance in pediatric burn injury survivors 24 to 36 months postburn. J Burn Care Res (2014) 0.78
Associations between diabetes self-management and microvascular complications in patients with type 2 diabetes. Epidemiol Health (2016) 0.77
Antagonizing Wnt pathway in diabetic retinopathy. Diabetes (2013) 0.77
Caspase-14 expression impairs retinal pigment epithelium barrier function: potential role in diabetic macular edema. Biomed Res Int (2014) 0.77
The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus. Curr Cardiol Rep (2010) 0.77
The Nonmydriatic Fundus Camera in Diabetic Retinopathy Screening: A Cost-Effective Study with Evaluation for Future Large-Scale Application. J Ophthalmol (2016) 0.77
Neuropeptides and diabetic retinopathy. Br J Clin Pharmacol (2013) 0.77
Reversal of the Caspase-Dependent Apoptotic Cytotoxicity Pathway by Taurine from Lycium barbarum (Goji Berry) in Human Retinal Pigment Epithelial Cells: Potential Benefit in Diabetic Retinopathy. Evid Based Complement Alternat Med (2012) 0.77
An analysis of the association between a polymorphism of KCNJ11 and diabetic retinopathy in a Chinese Han population. Eur J Med Res (2015) 0.77
Effects of fenofibrate on adiponectin expression in retinas of streptozotocin-induced diabetic rats. J Diabetes Res (2014) 0.77
Haptoglobin2-2 phenotype is an additional risk factor of retinopathy in type 2 diabetes mellitus. Indian J Hum Genet (2013) 0.76
Aldose reductase inhibitor counteracts the enhanced expression of matrix metalloproteinase-10 and improves corneal wound healing in galactose-fed rats. Mol Vis (2013) 0.76
Label free measurement of retinal blood cell flux, velocity, hematocrit and capillary width in the living mouse eye. Biomed Opt Express (2016) 0.76
Telomere mean length in patients with diabetic retinopathy. Sci Rep (2015) 0.76
Chicken embryos as a potential new model for early onset type I diabetes. J Diabetes Res (2014) 0.76
Retinopathy Signs Improved Prediction and Reclassification of Cardiovascular Disease Risk in Diabetes: A prospective cohort study. Sci Rep (2017) 0.75
Relation of Serum and Vitreous Concentrations of Fetuin-A with Diabetic Retinopathy. Med Sci Monit (2015) 0.75
Activation of the stress response kinase JNK attenuates insulin action in retina through a p70S6K1 dependent mechanism. J Biol Chem (2016) 0.75
Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression. PLoS One (2016) 0.75
Overview of Ocular Anti-Vascular Endothelial Growth Factor Therapy in the Management of Diabetic Eye Complications. Diabetes Spectr (2016) 0.75
VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1. Prostaglandins Other Lipid Mediat (2016) 0.75
Pediatric diabetic retinopathy: experience of a tertiary hospital in Ethiopia. BMC Res Notes (2016) 0.75
A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression. Sci Rep (2016) 0.75
Diabetic retinopathy treated with laser photocoagulation and the indirect effect on glycaemic control. J Diabetes Res (2014) 0.75
Prevalence of diabetic retinopathy in a primary care setting using digital retinal imaging technology. Malays Fam Physician (2006) 0.75
Association of Serum Uric Acid Concentration with Diabetic Retinopathy and Albuminuria in Taiwanese Patients with Type 2 Diabetes Mellitus. Int J Mol Sci (2016) 0.75
The relationship of management modality in Saudi patients with type 2 diabetes to components of metabolic syndrome, γ glutamyl transferase and highly sensitive C-reactive protein. Ther Adv Chronic Dis (2016) 0.75
Pilot Study on Visual Function and Fundus Autofluorescence Assessment in Diabetic Patients. J Ophthalmol (2016) 0.75
Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant. Diabetes Metab Syndr Obes (2015) 0.75
Differential expression of microRNAs in retinal vasculopathy caused by selective Müller cell disruption. Sci Rep (2016) 0.75
Can technological solutions for diabetes replace islet cell function? Organogenesis (2011) 0.75
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol (2004) 13.78
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology (2012) 11.91
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28
A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol (2003) 9.99
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology (2003) 8.98
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08
Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med (2009) 6.75
The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol (2004) 6.53
Diabetic retinopathy. N Engl J Med (2012) 5.79
Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol (2006) 4.68
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (2005) 4.46
Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA (2010) 4.41
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Retinopathy in diabetes. Diabetes Care (2004) 4.25
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2011) 4.15
The impact of hearing loss on quality of life in older adults. Gerontologist (2003) 3.87
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol (2005) 3.74
Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology (2004) 3.53
Revised formulas for summarizing retinal vessel diameters. Curr Eye Res (2003) 3.47
Prevalence of olfactory impairment in older adults. JAMA (2002) 3.46
Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet (2008) 3.42
Age-related macular degeneration. Lancet (2008) 3.34
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol (2009) 3.21
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology (2005) 3.20
Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol (2003) 3.17
The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study. Arch Otolaryngol Head Neck Surg (2003) 3.17
Prevalence of refractive error in the United States, 1999-2004. Arch Ophthalmol (2008) 3.06
The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol (2007) 3.02
The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes (2006) 3.00
Panretinal photocoagulation for proliferative diabetic retinopathy. N Engl J Med (2011) 2.98
Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes (2010) 2.94
Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet (2003) 2.92
The economic burden of major adult visual disorders in the United States. Arch Ophthalmol (2006) 2.92
The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol (2006) 2.89
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet (2008) 2.89
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol (2009) 2.84
Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens (2014) 2.83
Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci (2006) 2.79
Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA (2002) 2.78
Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA (2002) 2.72
Long-term use of aspirin and age-related macular degeneration. JAMA (2012) 2.72
Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care (2002) 2.70
Visual acuity as an outcome measure in clinical trials of retinal diseases. Ophthalmology (2007) 2.69
The Los Angeles Latino Eye Study: design, methods, and baseline data. Ophthalmology (2004) 2.68
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology (2012) 2.68
ACE-I and ARBs in early diabetic nephropathy. J Renin Angiotensin Aldosterone Syst (2002) 2.64
Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study. Arch Intern Med (2006) 2.60
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet (2008) 2.49
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet (2013) 2.36
The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study. Ophthalmology (2003) 2.36
Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34
Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med (2009) 2.31
Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology (2004) 2.26
Generational differences in the prevalence of hearing impairment in older adults. Am J Epidemiol (2009) 2.18
Retinal arteriolar diameter and risk for hypertension. Ann Intern Med (2004) 2.18
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. Ann Intern Med (2009) 2.14
The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol (2007) 2.12
Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology (2004) 2.12
Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ (2004) 2.10
Low birthweight is associated with narrower arterioles in adults. Hypertension (2008) 2.08
Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds. Diabetes Care (2009) 2.08
Age-related macular degeneration and risk for stroke. Ann Intern Med (2006) 2.07
Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology (2003) 2.04
Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci (2002) 2.03
Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetes. Retina (2014) 2.03
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet (2012) 1.96
The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol (2008) 1.93
Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care (2006) 1.93
The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci (2002) 1.92
Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci (2005) 1.92
Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology (2006) 1.91
Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. Stroke (2010) 1.91
Quantitative and qualitative retinal microvascular characteristics and blood pressure. J Hypertens (2011) 1.89
Retinal vessel diameters and risk of hypertension: the Multiethnic Study of Atherosclerosis. J Hypertens (2009) 1.89
Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med (2004) 1.89
Blindness, visual impairment and the problem of uncorrected refractive error in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci (2002) 1.86
Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol (2008) 1.85
Retinal venular diameter as an early indicator of progression to proliferative diabetic retinopathy with and without high-risk characteristics in African Americans with type 1 diabetes mellitus. Arch Ophthalmol (2011) 1.85
Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis. Hypertension (2007) 1.83
EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet (2009) 1.82
Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology (2003) 1.81
Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA (2002) 1.80
Genome-wide linkage study of retinal vessel diameters in the Beaver Dam Eye Study. Hypertension (2006) 1.80
Identification of novel genetic loci for intraocular pressure: a genomewide scan of the Beaver Dam Eye Study. Arch Ophthalmol (2007) 1.79
Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke (2005) 1.78
Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke (2002) 1.77
The prevalence of hearing impairment and associated risk factors: the Beaver Dam Offspring Study. Arch Otolaryngol Head Neck Surg (2011) 1.76
Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study. Ophthalmology (2009) 1.76
Risk assessment model for development of advanced age-related macular degeneration. Arch Ophthalmol (2011) 1.75
Frailty, morbidity and survival. Arch Gerontol Geriatr (2005) 1.75